Three-year Study Shows Good Efficacy and Safety for Copaxone in MS: Presented at ECTRIMS
By Bruce Sylvester THESSALONIKI, GREECE -- October 5, 2005 -- A 3-year study of patients with ... more »
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Multiple Sclerosis Info
If you want this blog to continue, than make it financialy viable for Bonnie to continue it. She puts in 2-3 hours a day into this blog, and spends money on it for it's upkeep.
Search
This Month
|
« Previous
Sunday, October 30
by
All About MS
on Sun 30 Oct 2005 12:00 AM CST
Three-year Study Shows Good Efficacy and Safety for Copaxone in MS: Presented at ECTRIMS
Wednesday, October 26
by
All About MS
on Wed 26 Oct 2005 12:00 AM CST
A randomized, multicentre, open-label, parallel-group trial of the tolerability of interferon beta-1a (Rebif) administered by autoinjection or manual injection in relapsing-remitting multiple sclerosis.
Mikol D, Lopez-Bresnahan M, Taraskiewicz S, ... more » Monday, October 24
by
All About MS
on Mon 24 Oct 2005 12:00 AM CST
Randomized controlled trial of an energy conservation course for persons with multiple sclerosis. Saturday, October 22
by
All About MS
on Sat 22 Oct 2005 12:00 AM CST
Factors related to employment status changes in individuals with multiple sclerosis. Thursday, October 13
by
All About MS
on Thu 13 Oct 2005 10:46 AM CST
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||